SALUDA MEDICAL EUROPE LIMITEDActive

Company number 10345877Private limited companyIncorporated 2016

Key figures

£29,358+111.2%
Net assets 2024/25
-39.2%
Average annual change 2019/20–2024/25
-400 k-200 k0200 k400 k600 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, SALUDA MEDICAL EUROPE LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Turnover1,945,744————
Cash at bank and in hand345,098123,722504,954201,972318,965
Total assets1,788,1071,433,0752,006,7081,063,8492,639,740
Total liabilities2,193,5231,796,9752,287,2841,310,8992,598,028
Net assets / total equity418,137-378,710-295,386-261,85929,358
Average number of employees1314131416

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: SALUDA MEDICAL EUROPE LIMITED

Company

SALUDA MEDICAL EUROPE LIMITED is a private limited company registered with Companies House under company number 10345877. It was incorporated on 25 Aug 2016. Its status is active. The registered office is in Harrogate (HG2). Its nature of business (SIC 2007) is retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files abridged accounts (unaudited). Net assets were £29,358, up 111.2% on the previous year. Cash at bank and in hand was £318,965. Total assets were £2,639,740 and total liabilities £2,598,028. The company had an average of 16 employees. Figures are available for 6 financial years (2019/20–2024/25).

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 7 Sep 2027.